Unknown NA INTERVENTIONAL 2-arm NCT02258984

Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial

Sponsor: Mespere Lifesciences Inc.

Conditions Acute Heart Failure Severe Sepsis

Interventions Mespere Venus 1000 Non-Invasive CVP System

Updated 7 times since 2017 Last updated: Sep 25, 2015 Started: Oct 31, 2014 Primary completion: Nov 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02258984, this NA trial focuses on Acute Heart Failure and Severe Sepsis and remains ongoing. Sponsored by Mespere Lifesciences Inc., it has been updated 7 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Oct 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Oct 2017 [monthly]

Enrolling By Invitation NA
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mespere Lifesciences Inc.
Wayne State University

Data source: Mespere Lifesciences Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Detroit, United States